Enzymatix Limited was undoubtedly one of the most important, groundbreaking start-up companies in the history of the European biotechnology industry. It was the first true biotech start-up in the UK and Europe.

7a_cloning_and_biocatalysis__5th_line_of_pics__341x256  picture1_195x242  picture2_212x139

book_front_cover_105x138Enzymatix Limited was undoubtedly one of the most important, groundbreaking start-up companies in the history of the European biotechnology industry. It was the first true biotech start-up in the UK and Europe
Enzymatix was founded by Sir Chris  as a young scientist at the age of 28 in 1987, with a vast array of potential new products based on his own original ideas.

picture3_111x166Enzymatix went on to spawn Celsis and Chiroscience, two of the most important companies in the UK sector in the 1990s.

Enzymatix developed and commercialised its own unique enzyme technology that led to the discovery and development of novel products such as premature baby lung surfactant, chiral gama-lactam, sketoprofen, rapid assay bioluminescent kits etc.

2_enzymatix_slide3_140x205The Enzymatix team also went on to develop ultra pure phospholipids, a range of pharmaceutical chiral synthons for drug synthesis and a number of high quality clinical diagnostic reagents and pharmaceutical biocatalysts.

enzymatic_1_154x155The company established itself as a true, $ multi-million revenue business by selling all of its own in-house generated products to pharmaceutical customers.

It was the forerunner to all biotech start-up companies in Britain and Europe. Even today, some 23 years later, very few small biotech companies could match the diversity of successful products developed by Enzymatix in the 1980s.

The business was eventually split into six parts and each sold off over time by Sir Chris in a string of $ multi-million deals which heralded the true beginnings of Sir Chris’s remarkable entrepreneurial journey.

enzymatix_337x253